BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

WRBY

Warby Parker Inc.
NYSE · Ophthalmic goods (SIC 3851) · FY ends 31 Dec

Revenue, quarterly

$236M+9.8% year on year
$300M$200M$100M$0
Q1 ’22Q1 ’23Q2 ’24Q2 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

54.7%+0.2 pp year on year
58%56%54%52%
Q4 ’22Q4 ’23Q3 ’24Q3 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$293M+2.2% year on year
$300M$200M$100M$0
Q4 ’21Q1 ’23Q1 ’24Q2 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

$22M−58.5% year on year
$100M$50M$0−$50M
Q4 ’22Q4 ’23Q3 ’24Q3 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty